Salazosulfapyridine


Combined with:

Prednisolone

Indications and Reactions:

Role Indications Reactions
Secondary
Rheumatoid Arthritis 58.0%
Drug Use For Unknown Indication 7.8%
Prophylaxis 6.3%
Product Used For Unknown Indication 3.9%
Arrhythmia 2.7%
Crohn's Disease 2.4%
Osteoporosis Prophylaxis 2.4%
Pain Prophylaxis 2.4%
Tuberculosis 2.0%
Diffuse Large B-cell Lymphoma 1.6%
Hypertension 1.6%
Prophylaxis Against Gastrointestinal Ulcer 1.6%
Oedema 1.2%
Pulmonary Tuberculosis 1.2%
Pustular Psoriasis 1.2%
Gastric Ulcer 0.8%
Ill-defined Disorder 0.8%
Inflammatory Pain 0.8%
Osteoporosis 0.8%
Psoriasis 0.8%
Urinary Tract Infection 18.4%
Drug Eruption 7.9%
Rheumatoid Arthritis 7.9%
Tuberculosis 7.9%
Meningitis Aseptic 5.3%
Nutritional Condition Abnormal 5.3%
Pneumonia Legionella 5.3%
Pregnancy 5.3%
Squamous Cell Carcinoma 5.3%
Traumatic Lung Injury 5.3%
Bursa Injury 2.6%
Drug Rash With Eosinophilia And Systemic Symptoms 2.6%
Exposure During Pregnancy 2.6%
Hypersensitivity 2.6%
Hypertension 2.6%
Liver Disorder 2.6%
Nodule 2.6%
Pleurisy 2.6%
Pre-eclampsia 2.6%
Sinusitis 2.6%
Concomitant
Rheumatoid Arthritis 54.4%
Product Used For Unknown Indication 9.4%
Prophylaxis 9.0%
Drug Use For Unknown Indication 5.6%
Colitis Ulcerative 3.8%
Psoriatic Arthropathy 2.3%
Adverse Event 2.2%
Hypertension 1.9%
Gastritis Prophylaxis 1.7%
Antibiotic Prophylaxis 1.6%
Osteoporosis 1.6%
Prophylaxis Against Gastrointestinal Ulcer 1.1%
Osteoporosis Prophylaxis 1.0%
Gastritis 0.9%
Analgesic Therapy 0.8%
Crohn's Disease 0.7%
Gastrointestinal Disorder 0.6%
Pulmonary Tuberculosis 0.6%
Behcet's Syndrome 0.5%
Diabetes Prophylaxis 0.5%
Pneumonia 12.2%
Pyrexia 7.3%
Varices Oesophageal 7.3%
Anal Abscess 6.5%
White Blood Cell Count Decreased 6.5%
Interstitial Lung Disease 4.9%
Occult Blood Positive 4.9%
Rash 4.9%
Rheumatoid Arthritis 4.9%
Wound Infection 4.9%
Metastases To Liver 4.1%
Renal Impairment 4.1%
Respiratory Failure 4.1%
Spinal Compression Fracture 4.1%
Biloma 3.3%
Pneumonia Bacterial 3.3%
Respiratory Disorder 3.3%
Suffocation Feeling 3.3%
Transient Ischaemic Attack 3.3%
Ventricular Extrasystoles 3.3%

Drug Data